What is Bausch Health Companies's market cap?

Bausch Health Companies (BHC) has a market capitalization of $1.7B and trades on NYSE.

What is Bausch Health Companies's revenue and profitability?

Bausch Health Companies generated $10.5B in trailing twelve-month revenue with a net loss of $1.2B, representing a net margin of -1.9%. Gross margin stands at 71.4%, with free cash flow of $1.0B. These figures are based on the Q1 2026 filing.

Who are Bausch Health Companies's competitors?

Bausch Health Companies's key competitors include AbbVie, Bausch + Lomb Corporation, Johnson & Johnson, and others. These companies compete in similar markets and product categories.

What subsidiaries does Bausch Health Companies have?

Bausch Health Companies's subsidiaries include Bausch + Lomb Corporation, Salix Pharmaceuticals, Solta Medical.

Where is Bausch Health Companies headquartered?

Bausch Health Companies is headquartered in Canada and employs approximately 20,270 people. It has been publicly traded since 1994.

Bausch Health Companies

BHC

Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company focused on gastroenterology, hepatology, neurology, dermatology, and eye health.

Market cap

$1.67B-29.1%

Revenue$10.5B+8.2%

Net income-$1.2B-548%

Free cash flow$1.0B-16.2%

EPS (diluted)-$3.10-560%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

July 29, 2026

Read the full report

Next report

Date not yet announced

Financials

Q1 2026

Income statement

See full

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

See full

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

See full

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation & ratios

Valuation

See full

Market cap$1.67B-29.1%

Enterprise value$21.13B-6.3%

P/S0.2×-0.1×

Profitability

See full

Operating margin5.6%-10.3pp

FCF margin9.8%-2.8pp

Returns & leverage

See full

Current ratio1.3×0.0×

Segments

By segment

See full

Bausch + Lomb$1.2B+9.4%

Salix$639.0M+17.9%

International$285.0M+8.8%

Diversified$185.0M-9.8%

Solta Medical$171.0M+51.3%

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

AbbVie$453.91B+36.3%

Alcon$32.8B-26.4%

Bausch + Lomb$5.8B+13.7%

PBH

Prestige Consumer Healthcare$2.4B-36.4%

Bausch Health Companies$1.7B-34.3%

HRO

Harrow$1.4B+9.1%

Cumberland Pharmaceuticals$105.3M+102%

By revenue growth

Bausch Health Companies+8.2%

Johnson & Johnson+8.1%

Cumberland Pharmaceuticals+2.1%

PBH

Prestige Consumer Healthcare-4.3%

By net margin

Johnson & Johnson21.48%-3.5pp

PBH

Prestige Consumer Healthcare17.48%-1.4pp

AbbVie5.79%-1.5pp

Bausch Health Companies-1.88%-9.1pp

Bausch + Lomb-3.21%+2.4pp

Cumberland Pharmaceuticals-17.6%-9.6pp

HRO

Harrow-19.75%+1.0pp

Profile

Bausch Health Companies Inc. is a global specialty pharmaceutical and medical device company focused on gastroenterology, hepatology, neurology, dermatology, and eye health. The company develops, manufactures, and markets a diverse portfolio of branded and generic pharmaceuticals, over-the-counter products, and aesthetic medical devices across approximately 90 countries. A significant portion of its operations is conducted through its majority ownership of Bausch + Lomb, a leading global eye health business.

Competitive position

A leading global player in gastroenterology and eye health with a diversified portfolio of high-barrier-to-entry medical devices and branded pharmaceuticals.

GeographiesUnited States, Canada, Europe, Asia-Pacific, Latin America

Customer segmentsHealthcare Providers, Retail Consumers, Wholesale Distributors, Hospitals

Business modelManufacturing, Research and Development, Direct Sales, Licensing

SuppliersActive Pharmaceutical Ingredient (API) suppliers, Specialized medical component manufacturers, Contract research organizations (CROs)

CustomersPharmaceutical wholesalers, Retail pharmacy chains, Hospitals and surgical centers, Direct-to-consumer retail

CountryCanada

Listed1994

Employees20.3K

CEOThomas J. Appio

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Websitebauschhealth.com

FilingsSEC EDGAR

Ask your AI about Bausch Health Companies.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch Health Companies's market cap?: Bausch Health Companies (BHC) has a market capitalization of $1.7B and trades on NYSE.
What is Bausch Health Companies's revenue and profitability?: Bausch Health Companies generated $10.5B in trailing twelve-month revenue with a net loss of $1.2B, representing a net margin of -1.9%. Gross margin stands at 71.4%, with free cash flow of $1.0B. These figures are based on the Q1 2026 filing.
Who are Bausch Health Companies's competitors?: Bausch Health Companies's key competitors include AbbVie, Bausch + Lomb Corporation, Johnson & Johnson, and others. These companies compete in similar markets and product categories.
What subsidiaries does Bausch Health Companies have?: Bausch Health Companies's subsidiaries include Bausch + Lomb Corporation, Salix Pharmaceuticals, Solta Medical.
Where is Bausch Health Companies headquartered?: Bausch Health Companies is headquartered in Canada and employs approximately 20,270 people. It has been publicly traded since 1994.